Navigation Links
Amplified Fragment Length Polymorphism (AFLP) Analysis on Applied Biosystems Capillary Electrophoresis Systems

Introduction

Amplified fragment length polymorphism (AFLP) analysis is a genetic mapping technique that uses selective amplification of a subset of restriction enzyme-digested DNA fragments to generate a unique fingerprint for a particular genome. First developed for plant studies, AFLP analysis is used for a variety of applications, such as:

Creation of genetic maps for new species.

Determination of relatedness among cultivars

Establishment of linkage groups in crosses

Genetic diversity and molecular phylogeny studiesCreation of genetic maps for new species

Determination of relatedness among cultivars

Establishment of linkage groups in crosses

Genetic diversity and molecular phylogeny studies

The power of AFLP analysis derives from its ability to quickly generate large numbers of marker fragments for any organism, without prior knowledge of the genomic sequence. In addition, AFLP analysis requires only small amounts of starting template and can be used for a variety of genomic DNA samples.

The AFLP procedure consists of two amplification steps: a low-level or preselective amplification, followed by a more selective amplification, which generates a set of fragments that can be used as the discriminatory marker set for a particular sample (Figure 1).

Polymorphisms in band patterns map to specific loci, allowing individuals to be genotyped or differentiated based on the alleles they carry.

Performing Successful AFLP Analysis

The success of an AFLP assay depends on three factors:

1. Optimized reagents

2. A robust and reliable electrophoresis platform

3. Effective analysis software In this Application Note, we will use the Applied Biosystems Plant Mapping

Kit with genomic DNA samples from maize to demonstrate that the Applied Biosystems capillary electrophoresis platforms, the Applied Biosystems 3130 series Genetic Analyzers or the Applied Biosystems 3730 series DNA analyzers in conjunction with GeneMapper v.3.7 software or higher provides a complete solution that enables researchers to perform accurate and reproducible AFLP projects in a routine fashion.

The AFLP Assay

When setting up an AFLP assay, an optimization step may be necessary to identify those primer combinations that will generate sufficient unique marker fragments for a study. The Applied Biosystems Plant Mapping Kit contains eight selective EcoRI primers for regular plant genomes, eight selective EcoRI primers for small plant genomes and eight MseI primers. The primers are labeled with either 5-FAM, NED, or JOE fluorophores (dye set F). This kit allows researchers to choose from 128 possible primer combinations that have been tested across several crop genomes, enabling them to identify the optimal pair(s) for a given organism without having to design, synthesize, or perform quality control tests of their primers.

Capillary Electrophoresis

The Applied Biosystems 3130 series Genetic Analyzers and 3730 series DNA Analyzers are fully automated, high-performance, fluorescence-based, multi-capillary systems that can run 4 (3130 Genetic Analyzer), 16 (3130xl Genetic Analyzer), 48 (3730 DNA Analyzer) or 96 (3730xl DNA Analyzer) samples. Sample analysis on these instruments is fully automated, from the moment each 96- or 384-well plate is placed on the instrument and the run is initiated. Each of the systems provide continuous, unattended operation, from automated polymer loading and sample injection to separation, detection, and data generation. When the Autoanalysis feature of GeneMapper software is used for data analysis, the systems offer true onebutton operation from sample loading to data analysis. The instruments also contain several features, such as:

Enhanced sizing precision (Figure 2) from a detection cell heater that facilitates better thermal control

An automated polymer delivery system that significantly reduces set-up time and cost

Easy to use wizards for instrument operation

Automated Data Analysis with GeneMapper Software v3.7 or higher

Crucial to the successful completion of an AFLP assay is the availability of analysis software that can accurately and reproducibly score AFLP samples. GeneMapper Software v3.7 or higher offers a new AFLP analysis method and several new features for accurate and reproducible AFLP analysis. These features include the ability to use the sample files to generate the panels which are the collection of markers for that sample set. In addition, the software also contains a custom plot feature that allows multiple plots, each with a unique color, to be overlaid.

The software uses advanced analysis algorithms that can rapidly and accurately identify common and polymorphic peaks among large numbers of samples. Genotyping quality (GQ) scores flag sample data with lower quality for manual review.

When analysis is complete, the software automatically compiles the marker genotype results in a standard binary format (Table 1), which can be exported for further downstream analysis. The software also contains a convenient new Report Manager feature that generates reports containing final results that can be printed or exported for further analysis. Researchers can customize the format of these reports to meet the needs of their individual projects.

Parentage Testing with AFLP Analysis

To highlight the use of the 3130 and 3730 series platforms for AFLP analysis with a specific application, a parentage assay was performed on maize DNA samples isolated from three individuals:

1. Parent one (P1)

2. Parent two (P2)

3. The first-generation offspring (F1) from a cross between P1 and P2

Primers labeled with the 5-FAM dye from the Applied Biosystems AFLP starter kit were used for selective amplification, and the reaction products were analyzed using a 36-cm capillary array and POP-7 polymer. The reaction products were mixed with the GeneScan-500 ROX dye-labeled size standard and electrophoresed on the 3130xl Genetic Analyzer and the 3730xl DNA Analyzer using the following protocols:

FA_36_POP-7 run module and F dye set (3130xl Genetic Analyzer)

GeneMapper_36_POP-7 run module and Any4Dye set (3730xl DNA Analyzer)

For the 3730 series systems the user should review all the data from the spectral calibration when using the AnyDye feature to verify that no poor quality data was used. Condition Numbers and Quality Score boundaries should be optimized for each dye set. Refer to the BAC Fingerprinting on the Applied Biosystems 3730/3730xl DNA Analyzer application note (S/N 107AP04-01) for more detail on this procedure.

The peak patterns in the F1 sample are consistent with those of a cross between P1 and P2 (Figure 3). In addition to several non-polymorphic peaks in both P1 and P2, which are also present in F1 (black arrow in Figure 3), unique peaks present in the F1 sample that were inherited from one parent (red arrow in Figure 3) can also be identified. Researchers can use the custom plot colors option in GeneMapper software for easy identification of polymorphic peaks (red arrow) and common peaks (black arrow). For example, in the data shown in Figure 4, a polymorphic peak can be easily identified in the P1 sample (red arrow). The use of the POP-7 polymer offers advantages such as high resolution, especially for large fragment sizes, which should result in more accurate allele calling by GeneMapper software, and superior sizing precision (Figure 2) with reduced run times.

Conclusion

The Applied Biosystems capillary electrophoresis platforms, 3130/3130xl Genetic Analyzers and the 3730/3730xl DNA Analyzers, in conjunction with optimized AFLP primer kits and GeneMapper Software v3.7 or higher, provide a complete solution for performing AFLP assays. System features include high resolution, superior sizing precision, low turnaround times, and ease of use. The integration of GeneMapper software with these instruments provides one-button operation for sample loading, data collection, fragment size-calling, and accurate marker scoring in both graphical and standard binary formats. All of these features enable the generation of ample high-quality data with minimal hands-on time required and little need for manual data review.


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Fractionating DNA Fragments Generated by Differential Display PCR
2. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
3. Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping
4. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
5. Efficient Cloning and Electro-transformation of Large Eukaryotic DNA Fragments
6. Resolution of Linear DNA Fragments From 23 Kilobases to 6 Megabases Using Biphasic Linear Switch-Time Ramping
7. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
8. Genotyping Single Nucleotide Polymorphisms with Molecular Beacons
9. A Positive Selection Assay for Mutation Analysis in Big Blue Animals
10. Epitope-Tagging Vectors for Functional Analysis in Yeast
11. Map and Link Human Genetic Disorders with SSLP Analysis
Post Your Comments:
(Date:10/22/2014)... 22, 2014 Grace Century, a private ... projects, announces the addition of Dr. Yousef “Josh” ... advisory team. Dr. Siddiqui will provide further healthcare expertise ... graduate of University College Medical School in ... medicine in 2001. With further certification as a General ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 The ... (Medication Dispensing Systems, Packaging and Labeling Systems, Table-top ... Automation) - Global Forecasts & Trends to 2019” ... and opportunities in North America, Europe, Asia-Pacific, and ... 101 market tables and 30 figures spread through ...
(Date:10/20/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... to $5.8 million and provides a good start to Q4.  The ... America and one in the Middle East ... record levels," said Peter Bruijns , President & CEO. "Total ... Q3 than they have been for any complete year since the ...
Breaking Biology Technology:Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4
... to $33.2 Million, ... $12.8 Million, -- The Company Provides ... NEW YORK and HAIKOU, Hainan, China, March 31,/Xinhua-PRNewswire-FirstCall/ -- ... which develops, manufactures, and,markets generic and branded bio-pharmaceutical products ...
... on Lead Compounds That Directly and Specifically Activate ... ... Massachusetts, March 31 Mercury Therapeutics,Inc. (MTI), a company that discovers ... filed for patent protection on,three lead compounds that directly and specifically ...
... Vaccine Technology and ... Bird Flu Clinical Program, Webcast/teleconference Call Set ... March 31 Carrington,Laboratories, Inc. (OTC Bulletin Board: CARN) today reported ... ($0.90) per basic and,diluted share, for the year ended December 31, ...
Cached Biology Technology:China Pharma Holdings, Inc. Announces Record 2007 Year End Results 2China Pharma Holdings, Inc. Announces Record 2007 Year End Results 3China Pharma Holdings, Inc. Announces Record 2007 Year End Results 4China Pharma Holdings, Inc. Announces Record 2007 Year End Results 5China Pharma Holdings, Inc. Announces Record 2007 Year End Results 6China Pharma Holdings, Inc. Announces Record 2007 Year End Results 7China Pharma Holdings, Inc. Announces Record 2007 Year End Results 8China Pharma Holdings, Inc. Announces Record 2007 Year End Results 9China Pharma Holdings, Inc. Announces Record 2007 Year End Results 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 11Mercury Therapeutics Patents Filed 2Mercury Therapeutics Patents Filed 3Carrington Reports 2007 Financial Results 2Carrington Reports 2007 Financial Results 3Carrington Reports 2007 Financial Results 4Carrington Reports 2007 Financial Results 5Carrington Reports 2007 Financial Results 6Carrington Reports 2007 Financial Results 7
(Date:10/16/2014)... be cultivated efficiently, they are anything but sustainable: ... monoculture cultivation is becoming increasingly evident. Despite their ... and are regarded as the sole possibility of ... wrongfully, finds Bernhard Schmid, an ecology professor at ... form of agriculture and forestry. After all, a ...
(Date:10/15/2014)... PORT WASHINGTON, N.Y. , Oct. 15, 2014 ... in technology solutions for home and community-based care, ... the benefits of implementing Sandata,s Santrax® Electronic Visit ... Quality Care Services is a home health company ... Texas . ...
(Date:10/15/2014)... spreading rapidly and to an unexpected extent. The outbreak ... and the virus shows a new disease dynamic in ... this reason, the German National Academy of Sciences Leopoldina, ... and the Union of the German Academies of Sciences ... epidemic today. , In the statement the academies call ...
Breaking Biology News(10 mins):Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
... 2012 Aware, Inc. (NASDAQ: AWRE ), a leading ... financial results for its first quarter ended March 31, 2012.  ... million, a decrease of 10% compared to $6.4 million in the ... 2012 was $1.1 million, or $0.05 per diluted share. These results ...
... Huntington disease (HD) is an inherited neurodegenerative disorder ... the Huntingtin gene, a CAG repeat occurs too many ... or 50s, but studies have shown that significant brain ... diagnosis. As a result, the field has sought a ...
... of Plant Biologists (ASPB) is pleased to announce the recipients ... and service. Charles Reid Barnes Life Membership ... University of Florida, Gainesville , Established in 1925, the ... honoring lifelong service in plant biology. Hanson, this year,s honoree, ...
Cached Biology News:Aware, Inc. Reports First Quarter 2012 Financial Results 2Aware, Inc. Reports First Quarter 2012 Financial Results 3Aware, Inc. Reports First Quarter 2012 Financial Results 4Aware, Inc. Reports First Quarter 2012 Financial Results 5Striatal brain volume predicts Huntington disease onset 2ASPB names 2012 award recipients 2ASPB names 2012 award recipients 3ASPB names 2012 award recipients 4ASPB names 2012 award recipients 5
MOUSE ANTI HUMAN CYTOKERATIN 1-8...
Immunogen: Tissue / cell preparation. (Murine EHS laminin preparation) Storage: -20 C, Avoid Freeze/Thaw Cycles...
p-Raf-1 (Ser 338/Tyr 341)-R...
Rabbit polyclonal to Syntrophin alpha 1 ( Abpromise for all tested applications). entrezGeneID: 6640 SwissProtID: Q13424...
Biology Products: